Foley Partner Stephen Maebius was quoted in an article that appeared in The Am Law Litigation Daily on September 28, 2011 titled “Hogan Lovells Knocks Out $29 Million Infringement Award Against HemCon.” Maebius discusses how the U.S. Patent and Trademark Office’s transition to inter partes review for determining patent validity supports the use of an “intervening rights” defense in patent disputes. He states that recent infringement claim decisions ease the way for defendants to assert an intervening rights defense, which will likely encourage more litigants to seek inter partes review hearings when they go into effect next year.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”